129 related articles for article (PubMed ID: 11917291)
1. Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (Ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.
Myerson R
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):86-90. PubMed ID: 11917291
[TBL] [Abstract][Full Text] [Related]
2. Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.
Myerson R; Zobeiri I; Birnbaum E; Dietz D; Fleshman J; Kodner I; Picus J; Ratkin G
Semin Oncol; 2002 Dec; 29(6 Suppl 19):29-33. PubMed ID: 12577240
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
4. Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients.
Dunst J; Semlin S; Pigorsch S; Müller AC; Reese T
Strahlenther Onkol; 2000 Sep; 176(9):416-21. PubMed ID: 11050915
[TBL] [Abstract][Full Text] [Related]
5. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
[TBL] [Abstract][Full Text] [Related]
6. Residual chromosomal damage after radiochemotherapy with and without amifostine detected by 24-color FISH.
Kuechler A; Dreidax M; Pigorsch SU; Liehr T; Claussen U; Wendt TG; Dunst J
Strahlenther Onkol; 2003 Jul; 179(7):493-8. PubMed ID: 12835887
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
8. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.
Videtic GM; Fisher BJ; Perera FE; Bauman GS; Kocha WI; Taylor M; Vincent MD; Plewes EA; Engel CJ; Stitt LW
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):319-24. PubMed ID: 9788410
[TBL] [Abstract][Full Text] [Related]
9. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results.
Ménard C; Camphausen K; Muanza T; Sears-Crouse N; Smith S; Ben-Josef E; Coleman CN
Semin Oncol; 2003 Dec; 30(6 Suppl 18):63-7. PubMed ID: 14727242
[TBL] [Abstract][Full Text] [Related]
11. [Immediate results of combined therapy for local recurrences of rectal cancer].
Korytova LI; Sandalevskaya AG; Krasnikoval VG; Korytov OV; Meshechkin AV
Vopr Onkol; 2015; 61(1):52-6. PubMed ID: 26016146
[TBL] [Abstract][Full Text] [Related]
12. Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer.
Kaminski A; Joseph D; Elsaleh H
Australas Radiol; 2007 Jun; 51(3):283-8. PubMed ID: 17504322
[TBL] [Abstract][Full Text] [Related]
13. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury.
Ben-Josef E; Han S; Tobi M; Vargas BJ; Stamos B; Kelly L; Biggar S; Kaplan I
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):81-5. PubMed ID: 11917290
[TBL] [Abstract][Full Text] [Related]
14. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
[TBL] [Abstract][Full Text] [Related]
15. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.
Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni ML; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F
Lung Cancer; 2000 Aug; 29(2):131-7. PubMed ID: 10963843
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
Créhange G; Bosset JF; Maingon P
Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
[TBL] [Abstract][Full Text] [Related]
19. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]